Komori
KYORIN Pharmaceutical (4569) · InitiativeRestated

Group-wide Compliance and Risk Management Framework

First written in FY2017. 3 of 4 entries say "Restated". Latest entry: FY2024.

4entries
8years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2017 – FY20242017: 120172018: 120182019: 120192020: 020202021: 020212022: 020222023: 020232024: 12024
Same theme, other companies
Compliance and Internal Control Across the Group (Including the CSR Committee)A theme 233 companies write about · 2 as a headwind · 233 as a tailwind

97 other companies' latest entry also says "Restated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 198 companies compared. The sentences above are computed from all 198.Comparing 200 of the theme's 235 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2024RestatedAnnual report

    「Each group company has established a Compliance Committee and a Risk Management Committee, which are overseen by the Company as it promotes the group-wide response to compliance and risk management.」

    The group-wide compliance and risk management framework, overseen by the Company through committees at each group company, remains in place.
  2. FY2019RestatedAnnual report

    「Each company in the Kyorin Pharmaceutical Group has a Compliance Committee and a Risk Management Committee, while the Group Compliance Committee and Group Risk Management Committee oversee and promote the group-wide response to compliance and risk management.」

    The compliance and risk management framework involving committees at each company and group-wide committees remains in place.
  3. FY2018RestatedAnnual report

    「We have established a framework in which each KYORIN Pharmaceutical Group company appoints personnel responsible for promoting compliance and managing risk, while the Compliance Committee and Risk Management Committee oversee and promote compliance and risk management across the Group.」

    The framework involving personnel at each company and group-wide compliance and risk management committees remains in place.
  4. FY2017First statedAnnual report

    「We have established a framework in which each KYORIN Pharmaceutical Group company appoints personnel responsible for promoting compliance and managing risk, while the Compliance Committee and Risk Management Committee oversee and promote compliance and risk management across the Group.」

    A Group-wide framework is described involving company-level personnel and the Compliance and Risk Management Committees.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for KYORIN Pharmaceutical yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.